Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice

Cinzia Pisani, G Strimpakos, F Gabanella, MG Di Certo, A Onori, C Severini, S Luvisetto, S Farioli-Vecchioli, I Carrozzo, A Esposito, T Canu, E Mattei, N Corbi, C Passananti

Research output: Contribution to journalArticle

Abstract

Up-regulation of the dystrophin-related gene utrophin represents a promising therapeutic strategy for the treatment of Duchenne Muscular Dystrophy (DMD). In order to re-program the utrophin expression level in muscle, we engineered artificial zinc finger transcription factors (ZF-ATFs) that target the utrophin ʻAʼ promoter. We have previously shown that the ZF-ATF “Jazz”, either by transgenic manipulation or by systemic adeno-associated viral delivery, induces significant rescue of muscle function in dystrophic “mdx” mice. We present the full characterization of an upgraded version of Jazz gene named “JZif1” designed to minimize any possible host immune response. JZif1 was engineered on the Zif268 gene-backbone using selective amino acid substitutions to address JZif1 to the utrophin ‘A’ promoter. Here, we show that JZif1 induces remarkable amelioration of the pathological phenotype in mdx mice. To investigate the molecular mechanisms underlying Jazz and JZif1 induced muscle functional rescue, we focused on utrophin related pathways. Coherently with utrophin subcellular localization and role in neuromuscular junction (NMJ) plasticity, we found that our ZF-ATFs positively impact the NMJ. We report on ZF-ATF effects on post-synaptic membranes in myogenic cell line, as well as in wild type and mdx mice. These results candidate our ZF-ATFs as novel therapeutic molecules for DMD treatment. © 2018
Original languageEnglish
Pages (from-to)1172-1182
Number of pages11
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1864
Issue number4
DOIs
Publication statusPublished - 2018

Fingerprint

Utrophin
Inbred mdx Mouse
Neuromuscular Junction
Zinc Fingers
Transcription Factors
Up-Regulation
Muscles
Duchenne Muscular Dystrophy
Genes
Synaptic Membranes
Dystrophin
Amino Acid Substitution
Phenotype
Cell Line
Therapeutics

Cite this

Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice. / Pisani, Cinzia; Strimpakos, G; Gabanella, F; Di Certo, MG; Onori, A; Severini, C; Luvisetto, S; Farioli-Vecchioli, S; Carrozzo, I; Esposito, A; Canu, T; Mattei, E; Corbi, N; Passananti, C.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, No. 4, 2018, p. 1172-1182.

Research output: Contribution to journalArticle

Pisani, C, Strimpakos, G, Gabanella, F, Di Certo, MG, Onori, A, Severini, C, Luvisetto, S, Farioli-Vecchioli, S, Carrozzo, I, Esposito, A, Canu, T, Mattei, E, Corbi, N & Passananti, C 2018, 'Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice', Biochimica et Biophysica Acta - Molecular Basis of Disease, vol. 1864, no. 4, pp. 1172-1182. https://doi.org/10.1016/j.bbadis.2018.01.030
Pisani, Cinzia ; Strimpakos, G ; Gabanella, F ; Di Certo, MG ; Onori, A ; Severini, C ; Luvisetto, S ; Farioli-Vecchioli, S ; Carrozzo, I ; Esposito, A ; Canu, T ; Mattei, E ; Corbi, N ; Passananti, C. / Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice. In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 2018 ; Vol. 1864, No. 4. pp. 1172-1182.
@article{8a170ad11c42480b86e1970625b46527,
title = "Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice",
abstract = "Up-regulation of the dystrophin-related gene utrophin represents a promising therapeutic strategy for the treatment of Duchenne Muscular Dystrophy (DMD). In order to re-program the utrophin expression level in muscle, we engineered artificial zinc finger transcription factors (ZF-ATFs) that target the utrophin ʻAʼ promoter. We have previously shown that the ZF-ATF “Jazz”, either by transgenic manipulation or by systemic adeno-associated viral delivery, induces significant rescue of muscle function in dystrophic “mdx” mice. We present the full characterization of an upgraded version of Jazz gene named “JZif1” designed to minimize any possible host immune response. JZif1 was engineered on the Zif268 gene-backbone using selective amino acid substitutions to address JZif1 to the utrophin ‘A’ promoter. Here, we show that JZif1 induces remarkable amelioration of the pathological phenotype in mdx mice. To investigate the molecular mechanisms underlying Jazz and JZif1 induced muscle functional rescue, we focused on utrophin related pathways. Coherently with utrophin subcellular localization and role in neuromuscular junction (NMJ) plasticity, we found that our ZF-ATFs positively impact the NMJ. We report on ZF-ATF effects on post-synaptic membranes in myogenic cell line, as well as in wild type and mdx mice. These results candidate our ZF-ATFs as novel therapeutic molecules for DMD treatment. {\circledC} 2018",
author = "Cinzia Pisani and G Strimpakos and F Gabanella and {Di Certo}, MG and A Onori and C Severini and S Luvisetto and S Farioli-Vecchioli and I Carrozzo and A Esposito and T Canu and E Mattei and N Corbi and C Passananti",
year = "2018",
doi = "10.1016/j.bbadis.2018.01.030",
language = "English",
volume = "1864",
pages = "1172--1182",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice

AU - Pisani, Cinzia

AU - Strimpakos, G

AU - Gabanella, F

AU - Di Certo, MG

AU - Onori, A

AU - Severini, C

AU - Luvisetto, S

AU - Farioli-Vecchioli, S

AU - Carrozzo, I

AU - Esposito, A

AU - Canu, T

AU - Mattei, E

AU - Corbi, N

AU - Passananti, C

PY - 2018

Y1 - 2018

N2 - Up-regulation of the dystrophin-related gene utrophin represents a promising therapeutic strategy for the treatment of Duchenne Muscular Dystrophy (DMD). In order to re-program the utrophin expression level in muscle, we engineered artificial zinc finger transcription factors (ZF-ATFs) that target the utrophin ʻAʼ promoter. We have previously shown that the ZF-ATF “Jazz”, either by transgenic manipulation or by systemic adeno-associated viral delivery, induces significant rescue of muscle function in dystrophic “mdx” mice. We present the full characterization of an upgraded version of Jazz gene named “JZif1” designed to minimize any possible host immune response. JZif1 was engineered on the Zif268 gene-backbone using selective amino acid substitutions to address JZif1 to the utrophin ‘A’ promoter. Here, we show that JZif1 induces remarkable amelioration of the pathological phenotype in mdx mice. To investigate the molecular mechanisms underlying Jazz and JZif1 induced muscle functional rescue, we focused on utrophin related pathways. Coherently with utrophin subcellular localization and role in neuromuscular junction (NMJ) plasticity, we found that our ZF-ATFs positively impact the NMJ. We report on ZF-ATF effects on post-synaptic membranes in myogenic cell line, as well as in wild type and mdx mice. These results candidate our ZF-ATFs as novel therapeutic molecules for DMD treatment. © 2018

AB - Up-regulation of the dystrophin-related gene utrophin represents a promising therapeutic strategy for the treatment of Duchenne Muscular Dystrophy (DMD). In order to re-program the utrophin expression level in muscle, we engineered artificial zinc finger transcription factors (ZF-ATFs) that target the utrophin ʻAʼ promoter. We have previously shown that the ZF-ATF “Jazz”, either by transgenic manipulation or by systemic adeno-associated viral delivery, induces significant rescue of muscle function in dystrophic “mdx” mice. We present the full characterization of an upgraded version of Jazz gene named “JZif1” designed to minimize any possible host immune response. JZif1 was engineered on the Zif268 gene-backbone using selective amino acid substitutions to address JZif1 to the utrophin ‘A’ promoter. Here, we show that JZif1 induces remarkable amelioration of the pathological phenotype in mdx mice. To investigate the molecular mechanisms underlying Jazz and JZif1 induced muscle functional rescue, we focused on utrophin related pathways. Coherently with utrophin subcellular localization and role in neuromuscular junction (NMJ) plasticity, we found that our ZF-ATFs positively impact the NMJ. We report on ZF-ATF effects on post-synaptic membranes in myogenic cell line, as well as in wild type and mdx mice. These results candidate our ZF-ATFs as novel therapeutic molecules for DMD treatment. © 2018

U2 - 10.1016/j.bbadis.2018.01.030

DO - 10.1016/j.bbadis.2018.01.030

M3 - Article

VL - 1864

SP - 1172

EP - 1182

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 4

ER -